Urinary Proteome Differences in Patients with Type 2 Diabetes Pre and Post Liraglutide Treatment

Diabetes mellitus is a chronic multisystem disease with a high global prevalence. The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is known to lower glucose levels and reduce weight. However, the mechanisms underlying the benefits of liraglutide treatment in patients with type 2 diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafiullah, Mohamed, Benabdelkamel, Hicham, Masood, Afshan, Ekhzaimy, Aishah A., Musambil, Mohthash, Joy, Salini Scaria, Alfadda, Assim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956006/
https://www.ncbi.nlm.nih.gov/pubmed/36826037
http://dx.doi.org/10.3390/cimb45020092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956006/
https://www.ncbi.nlm.nih.gov/pubmed/36826037
http://dx.doi.org/10.3390/cimb45020092

Ejemplares similares